Advertisement
Screener

AtriCure, Inc. (ATRC) Deferred Foreign Income Tax Expense (Benefit)

3.0 / 5 stars · 59/97 Roast Me

AtriCure, Inc. Deferred Foreign Income Tax Expense (Benefit)

AtriCure, Inc. (ATRC) reported Deferred Foreign Income Tax Expense (Benefit) of -$1.27 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-19

  • AtriCure, Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was -$1.27M.
  • AtriCure, Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was -$1.38M.
  • AtriCure, Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was -$3.67M.
  • AtriCure, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was -$1.64M.
Period endDeferred Foreign Income Tax Expense (Benefit) 12 month
2025-12-31-$1.27M
10-K · filed 2026-02-19
2024-12-31-$1.38M
10-K · filed 2026-02-19
2023-12-31-$3.67M
10-K · filed 2026-02-19
2022-12-31-$1.64M
10-K · filed 2025-02-14
2021-12-31-$826.00K
10-K · filed 2024-02-16
2020-12-31-$3.07M
10-K · filed 2023-02-22
2019-12-31-$1.69M
10-K · filed 2022-02-17
2018-12-31$45.00K
10-K · filed 2021-02-26
2017-12-31-$2.24M
10-K · filed 2020-02-24
2016-12-31-$1.18M
10-K · filed 2019-03-01
2015-12-31-$955.00K
10-K · filed 2018-02-28
2014-12-31-$579.00K
10-K · filed 2017-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
Heartflow, Inc. (HTFL)United States$4.225B
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14